Who Paid My Doc
Nicholas Grimaldi
Orthopaedic Surgery Columbia, SC Doctor of Osteopathy
NPI 1528080777 CMS profile 204747
114 Gateway Corporate Blvd Ste 240, Columbia, SC 29203
General payments
$203,347
Research payments
$0
Ownership & investment interest
$1,600,000
Through program year 2025, Nicholas Grimaldi of Columbia, SC is reported in the CMS Open Payments database as having received $203,347 across 168 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $1,600,000 across 4 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $189,902 | 32 | |
| 2024 | General | $803 | 20 | |
| 2023 | General | $2,464 | 26 | |
| 2022 | General | $2,426 | 23 | |
| 2021 | General | $2,508 | 21 | |
| 2020 | General | $1,460 | 20 | |
| 2019 | General | $3,783 | 26 | |
| 2024 | Ownership | $400,000 | 1 | |
| 2023 | Ownership | $400,000 | 1 | |
| 2022 | Ownership | $400,000 | 1 | |
| 2021 | Ownership | $400,000 | 1 |
Beside peers
- Nicholas Grimaldi
- Orthopaedic Surgery median
- Middle half of Orthopaedic Surgery
- National median
In program year 2025, general payments to Nicholas Grimaldi were reported at $189,902. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.
Show as a table
| Year | Nicholas Grimaldi | Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,783 | $644 | $140–$2,844 | $163 |
| 2020 | $1,460 | $312 | $75–$1,860 | $114 |
| 2021 | $2,508 | $520 | $117–$2,495 | $132 |
| 2022 | $2,426 | $598 | $128–$2,731 | $149 |
| 2023 | $2,464 | $461 | $128–$2,264 | $160 |
| 2024 | $803 | $497 | $134–$2,475 | $164 |
| 2025 | $189,902 | $563 | $147–$2,717 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 15 drugsPart D claims
994
Drug cost
$18,116
Branded share of claims
29.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Lidocaine-Prilocaine Lidocaine/Prilocaine | Brand | 41 | $8,468 | |
| Lidocaine | Generic | 42 | $2,901 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 178 | $1,671 | |
| Naloxone Hcl | Generic | 25 | $1,500 | |
| Tizanidine Hcl | Generic | 133 | $664 | |
| Cephalexin | Generic | 84 | $632 | |
| Meloxicam | Generic | 227 | $616 | |
| Celecoxib | Generic | 34 | $474 | |
| Mupirocin | Generic | 56 | $424 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 64 | $250 |
The 10 drugs with the highest cost, of 15 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 128 billing codesPaid by Medicare
$310,753
Medicare patients
323
Services billed
3,303
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 38% | |
| Depression | 37% | |
| COPD | 30% | |
| Ischemic heart disease | 29% | |
| Osteoporosis | 27% | |
| Chronic kidney disease | 24% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 150 | 1,852 | $1,323 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
2 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| EVENITY |
|
$47 | — | — |
| Prolia |
|
$47 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
168 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery in South Carolina
William Smith
Orthopaedic Surgery · Columbia, SC
Richard Frisch
Orthopaedic Surgery · Mt Pleasant, SC
Brent Ponce
Orthopaedic Surgery · Charleston, SC
Chi Lim
Orthopaedic Surgery · Spartanburg, SC
Todd Lansford
Orthopaedic Surgery · North Charleston, SC
Richard Marks
Orthopaedic Surgery · West Columbia, SC
Related records
Orthopaedic Surgery in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.